Literature DB >> 15906303

Comparison of [3,4-13C2]glucose to [6,6-2H2]glucose as a tracer for glucose turnover by nuclear magnetic resonance.

Eunsook S Jin1, John G Jones, Shawn C Burgess, Matthew E Merritt, A Dean Sherry, Craig R Malloy.   

Abstract

A recently introduced tracer, [3,4-(13)C(2)]glucose, was compared to the widely used tracer, [6,6-(2)H(2)]glucose, for measurement of whole-body glucose turnover. The rate of glucose production (GP) was measured in rats after primed infusions of [3,4-(13)C(2)]glucose, [6,6-(2)H(2)]glucose, or both tracers simultaneously followed by a constant infusion of tracer(s) over 90 min. Blood glucose was purified and converted into monoacetone glucose for analysis by (13)C NMR (for [3,4-(13)C(2)]glucose) or (1)H and (2)H NMR (for [6,6-(2)H(2)]glucose). The values of GP measured during infusion of each single tracer were not significantly different. In rats infused with both tracers simultaneously, GP was identical as reported by each tracer, 42 +/- 4 micromol/kg/min. Since (2)H and (13)C enrichment in glucose is typically much less than 2% for in vivo studies, [3,4-(13)C(2)]glucose does not interfere with measurements of (13)C or (2)H enrichment patterns and therefore is valuable when multiple metabolic pathways are being evaluated simultaneously.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15906303     DOI: 10.1002/mrm.20496

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  9 in total

1.  The effect of short-term fasting on liver and skeletal muscle lipid, glucose, and energy metabolism in healthy women and men.

Authors:  Jeffrey D Browning; Jeannie Baxter; Santhosh Satapati; Shawn C Burgess
Journal:  J Lipid Res       Date:  2011-12-03       Impact factor: 5.922

Review 2.  Stable isotope-resolved metabolomics and applications for drug development.

Authors:  Teresa W-M Fan; Pawel K Lorkiewicz; Katherine Sellers; Hunter N B Moseley; Richard M Higashi; Andrew N Lane
Journal:  Pharmacol Ther       Date:  2011-12-23       Impact factor: 12.310

Review 3.  Applications of NMR spectroscopy to systems biochemistry.

Authors:  Teresa W-M Fan; Andrew N Lane
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2016-02-06       Impact factor: 9.795

4.  Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver.

Authors:  Santhosh Satapati; Nishanth E Sunny; Blanka Kucejova; Xiaorong Fu; Tian Teng He; Andrés Méndez-Lucas; John M Shelton; Jose C Perales; Jeffrey D Browning; Shawn C Burgess
Journal:  J Lipid Res       Date:  2012-04-09       Impact factor: 5.922

5.  Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver.

Authors:  Justin A Fletcher; Stanisław Deja; Santhosh Satapati; Xiaorong Fu; Shawn C Burgess; Jeffrey D Browning
Journal:  JCI Insight       Date:  2019-04-23

6.  Use of (2)H(2)O for estimating rates of gluconeogenesis: determination and correction of error due to transaldolase exchange.

Authors:  Jeffrey D Browning; Shawn C Burgess
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-10-02       Impact factor: 4.310

7.  Alterations in hepatic glucose and energy metabolism as a result of calorie and carbohydrate restriction.

Authors:  Jeffrey D Browning; Brian Weis; Jeannie Davis; Santhosh Satapati; Matthew Merritt; Craig R Malloy; Shawn C Burgess
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

8.  Simultaneous tracers and a unified model of positional and mass isotopomers for quantification of metabolic flux in liver.

Authors:  Stanislaw Deja; Xiaorong Fu; Justin A Fletcher; Blanka Kucejova; Jeffrey D Browning; Jamey D Young; Shawn C Burgess
Journal:  Metab Eng       Date:  2019-12-28       Impact factor: 9.783

9.  Disposition of a Glucose Load into Hepatic Glycogen by Direct and Indirect Pathways in Juvenile Seabass and Seabream.

Authors:  João Rito; Ivan Viegas; Miguel A Pardal; Isidoro Metón; Isabel V Baanante; John G Jones
Journal:  Sci Rep       Date:  2018-01-11       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.